Security key
05156V102
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)
CUSIP: 05156V102
Q4 2019 13F Holders as of 31 Dec 2019
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 48,880,484
- Total 13F value
- $990,406,662
- Share change
- +22,368,072
- Put/Call ratio
- 34%
- SEC-reported price per share
- $20.26
- Number of holders
- 110
- Value change
- +$509,187,869
- Number of buys
- 65
- Number of sells
- 26
- Shares outstanding
- 130,441,060
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2019
Institutions
110
Top holders
10
AUPH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Aurinia Pharmaceuticals Inc. SEC filings
Aurinia Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05156V102
Recent filing periods:
Ownership snapshot
Top reported holders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
NEA Management Company, LLC
Disclosed value leader
NEA Management Company, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2019
13F
Lead comparable stake: 4%
Showing 1-6 of 15 holder rows.
Quick read
NEA Management Company, LLC leads the comparable SEC ownership view at 4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens NEA Management Company, LLC's linked filing trail.
Comparable ownership
Top 5
NEA Management Company, LLC
4%
ORBIMED ADVISORS LLC
2.7%
Polar Capital LLP
2.5%
Consonance Capital Management LP
2%
GOLDMAN SACHS GROUP INC
1.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
Company
|
4%
|
$27,622,000
5,172,683 shares
|
— | 30 Sep 2019 |
| ORBIMED ADVISORS LLC |
13F
Company
|
2.7%
|
$18,856,000
3,531,002 shares
|
— | 30 Sep 2019 |
| Polar Capital LLP |
13F
Company
|
2.5%
|
$17,690,000
3,312,723 shares
|
— | 30 Sep 2019 |
| Consonance Capital Management LP |
13F
Company
|
2%
|
$13,677,000
2,561,269 shares
|
— | 30 Sep 2019 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
1.3%
|
$8,831,000
1,653,702 shares
|
— | 30 Sep 2019 |
| FRANKLIN RESOURCES INC |
13F
Company
|
1.1%
|
$7,516,000
1,407,500 shares
|
— | 30 Sep 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
110
Shares
48,880,484
Rows available
110
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
68
Q4 2019 holders
110
Holder diff
42
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 value | Q4 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend